diagnosi
bacteri
infect
reli
isol
bacterium
rare
achiev
need
patient
manag
furthermor
cultur
poorli
suit
diagnosi
polymicrobi
infect
final
syndrom
approach
target
bacteria
virus
caus
syndrom
detect
specif
dna
sequenc
clinic
specimen
use
dna
microarray
altern
microarray
first
use
diagnost
tool
identifi
hantaviru
associ
outbreak
acut
respiratori
diseas
main
advantag
microarray
multiplex
enabl
explor
microbiota
pathogen
detect
bacteremia
respiratori
infect
digest
infect
circumst
dna
array
may
lack
sensit
provid
fals
neg
enrich
sampl
increas
sensit
furthermor
chip
allow
type
streptococcu
pneumonia
detect
resist
staphylococcu
aureu
mrsa
mycobacterium
tuberculosi
rifampicin
isoniazid
fluoroquinolon
howev
cost
high
technic
requir
remain
problem
routin
use
bacteri
infect
diagnost
technolog
le
diagnost
de
infect
repos
sur
lisol
du
qui
est
rarement
dan
le
temp
du
soin
la
cultur
est
mal
au
diagnost
de
infect
polymicrobienn
enfin
une
approch
syndromiqu
doit
cibler
en
le
et
le
viru
respons
dun
syndrom
une
altern
est
la
de
adn
dan
cliniqu
par
le
puce
adn
dont
la
applic
en
lidentif
dun
hantaviru
une
de
maladi
respiratoir
lavantag
essentiel
de
puce
adn
est
le
multiplexag
permett
lexplor
de
microbiot
et
la
de
au
cour
de
de
infect
respiratoir
et
de
infect
digest
situat
dan
laquel
le
puce
adn
peuvent
manquer
de
et
donner
de
une
denrichiss
du
peut
palier
cett
limit
le
puce
permett
le
typag
de
streptococcu
pneumonia
et
la
de
la
chez
staphylococcu
aureu
et
mycobacterium
tuberculosi
rifampicin
izoniasid
fluoroquinolon
le
et
la
demeur
deux
frein
au
en
routin
de
cett
technologi
pour
le
diagnost
de
infect
diagnosi
bacteri
infect
laboratori
reli
isol
bacterium
identif
antibiogram
direct
diagnost
approach
limit
delay
obtain
cultur
result
sometim
caregiv
presenc
noncultiv
bacteria
sampl
presenc
inhibitor
antibiot
inappropri
cultur
condit
capac
isol
differenti
variou
coloni
polymicrobi
sampl
exampl
around
bacteri
speci
digest
microbiotium
identifi
routin
cultur
techniqu
altern
direct
diagnost
detect
de
univers
gene
sequenc
rrna
rpob
pcr
follow
hybrid
fluoresc
oligonucleotid
probe
real
time
pcr
altern
product
pcr
amplif
may
hybrid
solid
base
fix
great
number
oligonucleotid
probe
use
dna
microarray
techniqu
review
articl
search
dna
microarray
ncbi
search
engin
http
wwwncbinlmnihgovpubm
give
refer
may
show
import
molecular
biolog
tool
describ
first
time
fig
dna
microarray
infecti
diseas
combin
give
refer
may
first
report
use
tool
diagnosi
hantaviru
infect
publish
dna
microarray
techniqu
adapt
southern
blot
replac
nylon
base
glass
silicon
slide
allow
coval
fixat
sever
thousand
oligonucleotid
probe
probe
correspond
univers
gene
rrna
rpob
genu
speci
serotyp
specif
gene
gene
code
resist
antibiot
toxin
gene
dna
microarray
techniqu
includ
sever
step
manual
automat
extract
nucleic
acid
clinic
sampl
amplif
pcr
label
amplif
product
fluoresc
cyanin
monochrom
label
less
expens
twocolor
one
better
reproduc
hybrid
label
nucleic
acid
hour
dna
microarray
later
scan
measur
specif
probedna
interact
sampl
interact
measur
fluoresc
numer
data
fig
total
time
procedur
inferior
hour
includ
time
hybrid
dna
microarray
avail
market
diagnosi
bacteri
infect
two
firm
agil
http
wwwagilentcom
affymetrix
http
www
affymetrixcomestor
current
market
custom
made
prefabr
chip
avail
franc
phylochip
tm
affymetrix
santa
clara
california
chip
carri
million
probe
nucleotid
allow
detect
rrna
gene
bacteri
speci
capitalbio
corpor
firm
beij
china
http
wwwcapitalbiocom
market
dna
chip
identif
determin
resist
profil
mycobacteri
speci
frequent
isol
laboratori
final
proveit
tm
sepsi
striparray
mobidiag
helsinki
finland
autom
system
coupl
pcr
stage
dna
microarray
analysi
detect
bacteria
respons
bacteremia
human
bodi
carri
interact
microorgan
call
microbiota
contain
ten
time
cell
human
bodi
time
gene
human
genom
dna
phylochip
tm
affymetrix
allow
investig
human
microbiota
fig
among
intestin
microbiota
count
bacteria
major
role
individu
homeostasi
diseas
three
team
studi
intestin
microbiota
dna
microarray
carri
probe
base
target
rrna
gene
detect
bacteri
speci
author
report
intestin
microbiota
includ
part
found
individu
belong
phyla
actinobacteria
firmicut
bacteroidet
part
specif
individu
dna
microarray
also
allow
observ
decreas
firmicut
increas
enterococcu
clostridium
difficil
escherichia
coli
shigella
flexneri
listeria
spp
speci
patient
present
crohn
diseas
compar
healthi
individu
oral
microbiota
also
investig
dna
microarray
detect
gene
rrna
probe
carri
nucleotid
human
oral
microb
identif
microarray
homim
allow
investig
explor
oral
microbiota
five
patient
present
oral
cancer
five
patient
present
precancer
oral
lesion
ten
healthi
control
author
second
studi
analyz
oral
microbiota
children
year
age
four
differ
group
accord
develop
stage
teeth
milk
teeth
earli
mix
dentit
late
mix
dentit
final
dentit
result
two
studi
prove
firmicut
bacteroidet
proteobacteria
actinobacteria
preval
phyla
oral
microbiota
depend
individu
dentit
proteobacteria
bacteroidet
final
dentit
group
contrari
group
preval
prevotella
increas
age
final
porphyromona
catonia
neisseiria
flavescen
significantli
correl
presenc
carri
three
dna
microarray
design
diagnosi
respiratori
infect
chip
target
variabl
region
gyrb
pare
bacteri
gene
detect
result
prove
chip
gave
reliabl
diagnosi
within
one
day
third
chip
detect
speci
mycobacteria
includ
mycobacterium
tuberculosi
allow
directli
analyz
sputum
sampl
patient
suspect
present
pulmonari
tuberculosi
along
ziehl
stain
cultur
agar
hundr
sixteen
sampl
found
posit
chip
neg
posit
sampl
also
posit
cultur
chip
identifi
cultureneg
sampl
later
chip
detect
mycobacterium
intracellular
three
patient
confirm
sequenc
strain
variou
studi
confirm
sensibl
specif
dna
microarray
compat
immedi
use
respiratori
tract
sampl
frequent
serogroup
enterotox
e
coli
common
limit
chip
sensibl
detect
inde
enteropathogen
salmonella
spp
campylobact
spp
present
low
inoculum
less
equal
organismsml
diarrhea
stool
inoculum
dna
microarray
threshold
detect
interfer
commens
speci
pcr
amplif
stage
pathogen
hybrid
partli
decreas
limit
one
dna
microarray
detect
enteropathogen
bacteria
e
coli
enterica
l
monocytogen
c
jejuni
fresh
food
sampl
twelv
ident
hybrid
zone
allow
analyz
differ
sampl
singl
slide
reduc
test
cost
three
dna
microarray
describ
diagnosi
bacteremia
chip
target
bacteri
gyrb
pare
detect
acinetobact
baumanii
enterococcu
faecali
enterococcu
faecium
h
influenza
klebsiella
pneumonia
l
monocytogen
n
meningitidi
aureu
epidermidi
streptococcu
agalactia
pneumonia
pyogen
meca
gene
associ
methicillin
resist
aureu
test
posit
hemocultur
neg
hemocultur
sensibl
specif
anoth
dna
microarray
target
intern
transcrib
spacer
region
locat
ribosom
subunit
carri
univers
posit
probe
control
two
probe
detect
gramposit
bacteria
probe
detect
gramneg
bacteria
nine
genu
specif
probe
enterococcu
listeria
staphylococcu
streptococcu
bacteroid
enterobacterklebsiella
haemophilu
pseudomona
serratia
speci
specif
probe
sensibl
blood
sampl
within
hour
proveit
tm
sepsi
striparray
includ
pcr
target
gene
gyrb
pare
identifi
gramposit
gramneg
bacteria
respons
bacteremia
meca
gene
associ
methicillin
resist
less
hour
test
blood
sampl
posit
cultur
prove
sensibl
specif
result
studi
prove
dna
microarray
perfectli
adapt
diagnosi
bacteremia
detect
methicillin
resist
aureu
sensibl
specif
faster
result
standard
method
reli
cultur
inde
two
studi
includ
hybrid
stage
last
less
hour
dna
microarray
target
gene
glycosyltransferas
gt
allow
type
pneumonia
strain
correl
serotyp
bacterium
includ
differ
serotyp
inde
serotyp
respons
pneumonia
infect
chip
first
use
gt
gene
molecular
target
allow
determin
serogroup
pneumonia
strain
singl
step
peterson
et
al
develop
dna
microarray
allow
identif
pathogen
bacteria
human
anim
target
gene
resist
antibiot
gene
virul
chip
carri
specif
probe
bacteri
gene
resist
probe
target
gene
resist
metal
specif
probe
gene
virul
probe
target
transfer
element
seven
probe
correspond
posit
control
specif
chip
assess
cultur
enterica
typhimurium
fusobacterium
necrosum
e
faecali
e
coli
littl
nonspecif
hybrid
observ
test
test
made
chip
allow
confirm
result
previou
studi
chip
detect
msrc
gene
strain
methicillin
resist
e
faecium
gene
strain
penicillin
resist
e
faecium
result
obtain
chip
confirm
pcr
dna
microarray
develop
detect
five
specif
aureu
gene
target
gene
rrna
gene
resist
antibiot
macrolid
lincosamid
streptogramin
tetracyclin
cotrimoxazol
aminoglycosid
ten
gene
code
toxin
chip
test
analyz
methicillin
resist
aureu
strain
second
chip
identifi
aureu
versu
nonaureu
gene
rrna
detect
gene
meca
blaz
methicillin
penicillin
resist
aac
ieaph
resist
aminoglycosid
erma
ermc
resist
streptogramin
msra
resist
macrolid
sensibl
specif
accord
molecular
target
nevertheless
atyp
result
observ
isol
given
signal
hybrid
gene
blaz
even
though
activ
detect
strain
one
isol
neg
detect
gene
blaz
activ
author
explain
prove
sequenc
variat
gene
blaz
level
studi
decreas
hybrid
time
minut
decreas
intens
fluoresc
tuberculosi
resist
rifampicin
relat
mutat
region
base
pair
gene
rpob
code
rna
polymeras
subunit
isoniazid
resist
partli
associ
mutat
gene
katg
code
catalaseperoxidas
partli
mutat
regul
gene
inha
dna
microarray
detect
variou
mutat
show
sensibl
specif
detect
rifampicin
resist
sensibl
specif
detect
isoniazid
resist
author
recommend
use
chip
screen
multidrug
resist
mdr
bacteria
tuberculosi
suspect
dna
microarray
diagnosi
infecti
diseas
first
describ
topic
great
number
public
fig
inde
dna
microarray
allow
microbiolog
diagnosi
within
hour
includ
hybrid
time
compat
delay
medic
manag
patient
dna
microarray
also
allow
multiplex
detect
adapt
syndrom
approach
infecti
diseas
diagnosi
diagnosi
polymicrobi
infect
extend
virus
author
agre
dna
microarray
sensibl
specif
least
equal
refer
test
nevertheless
design
chip
crucial
step
obtain
reliabl
result
variou
chosen
probe
similar
length
fusion
temperatur
optim
hybrid
condit
current
limit
stage
sever
team
solv
problem
crossreact
fix
slide
specif
probe
pathogen
redund
manner
current
standard
triplic
test
sampl
prepar
label
nucleic
acid
even
simplifi
routin
use
bacteriolog
laboratori
decreas
time
cost
test
integr
dna
microarray
among
avail
techniqu
diagnost
pointofcar
infecti
diseas
inde
current
avail
techniqu
real
time
pcr
immunochromatograph
method
rapid
diagnost
method
singl
pathogen
per
test
dna
microarray
advantag
allow
multiplex
diagnos
perfectli
adapt
syndrom
approach
infecti
diseas
diagnosi
